
Antibody Engineering & Therapeutics US 2026
Accelerate Your Pipeline with Cyagen's Models & CRO Expertise:From Target Validation to Proof-of-Concept
Featured Experts
Resources
Swags & Offers
Featured Experts
Reza Rezaei holds a Doctorate in Veterinary Medicine (DVM) as well as a Ph.D. and has been in biopharma sales since his graduation from Texas A&M University. He has extensive experience working with lab animals both as a clinical practitioner and a research scientist.
Dr. Jenny Shan (MD, PhD) brings decades of R&D experience from industry leaders like Regeneron, Moderna, J&J, EQRx, Apogee, and Curie.Bio.
Her expertise spans diverse modalities—antibodies, small molecules, ADCs, CAR-T, mRNA, siRNA, peptides, oligonucleotides, AAV, and gene editing—across oncology, immunology, cardiovascular, neuroscience, and ophthalmology.
As a strategic pipeline architect, Dr. Shan has advanced multiple programs from discovery to clinical development. She supported the IND and regulatory approvals for numerous biologics, contributing to blockbuster drugs such as Eylea, Dupixent, Carvykti, and Rybrevant.


Jonathan brings almost 20 years of global experience in marketing genomic technologies, digital science platforms, and precision medicine solutions. Prior to joining Cyagen, he held leadership roles at Thermo Fisher Scientific and Miltenyi Biotec, where he led high‑impact product launches, built integrated demand‑generation programs, and partnered with commercial teams worldwide to accelerate adoption of advanced life science tools. Jonathan earned his MBA from Carnegie Mellon University and his BS in Biochemistry and Cell Biology from UC San Diego.
Swags & Offers
